logo
logo

Alberto Santagostino Appointed As Chief Executive Officer and President of Agc Biologics

Oct 28, 20249 months ago

Position

President

Company

AGC Biologics

Alberto Santagostino
BothellBiotechnologyHealth Care

Description

AGC Biologics announced the appointment of Alberto Santagostino as the new Chief Executive Officer and President, effective November 1st. Alberto brings a distinguished career in biotech, pharma, and managing large-scale global CDMO operations, and will lead the company in delivering reliable services to biopharmaceutical developers without unnecessary complications.

Company Information

Company

AGC Biologics

Location

Bothell, Washington, United States

About

AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months